GlobalFoundries Files For US IPO

GlobalFoundries Inc (NASDAQ:GFS) filed for its U.S. initial public offering aiming for a Nasdaq listing. Mubadala, a United Arab Emirates state…
  • GlobalFoundries Inc (NASDAQ:GFS) filed for its U.S. initial public offering aiming for a Nasdaq listing. Mubadala, a United Arab Emirates state investment fund, owns the foundry wholly.
  • GlobalFoundries is yet to disclose the amount of money it plans to raise or how much Mubadala will control after the IPO.
  • GlobalFoundries operates five manufacturing sites: Dresden, Germany; Singapore; Malta, New York; Burlington, Vermont; and East Fishkill, New York.
  • GlobalFoundries manufactures chips for use in contactless payments, battery power management touch display drivers.
  • Qualcomm Inc (NASDAQ:QCOM), Broadcom Inc (NASDAQ:AVGO), Samsung Electronics Co Ltd (OTC:SSNLF), and Advanced Micro Devices Inc (NASDAQ:AMD) are among its largest customers.
  • The pandemic triggered remote work, study, and home entertainment, led to higher demand for electronic gadgets, laptops, monitors, and game consoles, fueling a chip crisis.
  • GlobalFoundries’ revenue climbed by 13% year-on-year to just over $3 billion in the first half of 2021. It reported a gross margin of close to 11%. The net loss narrowed to $(301) million.
  • Price Action: QCOM shares closed lower by 1.58% at $126.68 on Monday.
Total
0
Shares
Related Posts
Read More

Novartis Announced Plans to Petition the U.S. Supreme Court to Uphold Validity of the Gilenya Dosing Regimen Patent

Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied its petition to rehear the negative decision regarding the validity of US Patent No. 9,187,405, covering a dosing regimen for 0.5mg Gilenya. Novartis plans to file a petition seeking further review of the CAFC's decision with the US Supreme Court.

NVS